生成式对抗网络在增强脑肿瘤中的潜在作用。

IF 3.3 Q2 ONCOLOGY JCO Clinical Cancer Informatics Pub Date : 2024-07-01 DOI:10.1200/CCI.23.00266
Amr Muhammed, Rafaat A Bakheet, Karam Kenawy, Ahmed M A Ahmed, Muhammed Abdelhamid, Walaa Gamal Soliman
{"title":"生成式对抗网络在增强脑肿瘤中的潜在作用。","authors":"Amr Muhammed, Rafaat A Bakheet, Karam Kenawy, Ahmed M A Ahmed, Muhammed Abdelhamid, Walaa Gamal Soliman","doi":"10.1200/CCI.23.00266","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Contrast enhancement is necessary for visualizing, diagnosing, and treating brain tumors. Through this study, we aimed to examine the potential role of general adversarial neural networks in generating artificial intelligence-based enhancement of tumors using a lightweight model.</p><p><strong>Patients and methods: </strong>A retrospective study was conducted on magnetic resonance imaging scans of patients diagnosed with brain tumors between 2020 and 2023. A generative adversarial neural network was built to generate images that would mimic the real contrast enhancement of these tumors. The performance of the neural network was evaluated quantitatively by VGG-16, ResNet, binary cross-entropy loss, mean absolute error, mean squared error, and structural similarity index measures. Regarding the qualitative evaluation, nine cases were randomly selected from the test set and were used to build a short satisfaction survey for experienced medical professionals.</p><p><strong>Results: </strong>One hundred twenty-nine patients with 156 scans were identified from the hospital database. The data were randomly split into a training set and validation set (90%) and a test set (10%). The VGG loss function for training, validation, and test sets were 2,049.8, 2,632.6, and 4,276.9, respectively. Additionally, the structural similarity index measured 0.366, 0.356, and 0.3192, respectively. At the time of submitting the article, 23 medical professionals responded to the survey. The median overall satisfaction score was 7 of 10.</p><p><strong>Conclusion: </strong>Our network would open the door for using lightweight models in performing artificial contrast enhancement. Further research is necessary in this field to reach the point of clinical practicality.</p>","PeriodicalId":51626,"journal":{"name":"JCO Clinical Cancer Informatics","volume":null,"pages":null},"PeriodicalIF":3.3000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Potential Role of Generative Adversarial Networks in Enhancing Brain Tumors.\",\"authors\":\"Amr Muhammed, Rafaat A Bakheet, Karam Kenawy, Ahmed M A Ahmed, Muhammed Abdelhamid, Walaa Gamal Soliman\",\"doi\":\"10.1200/CCI.23.00266\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>Contrast enhancement is necessary for visualizing, diagnosing, and treating brain tumors. Through this study, we aimed to examine the potential role of general adversarial neural networks in generating artificial intelligence-based enhancement of tumors using a lightweight model.</p><p><strong>Patients and methods: </strong>A retrospective study was conducted on magnetic resonance imaging scans of patients diagnosed with brain tumors between 2020 and 2023. A generative adversarial neural network was built to generate images that would mimic the real contrast enhancement of these tumors. The performance of the neural network was evaluated quantitatively by VGG-16, ResNet, binary cross-entropy loss, mean absolute error, mean squared error, and structural similarity index measures. Regarding the qualitative evaluation, nine cases were randomly selected from the test set and were used to build a short satisfaction survey for experienced medical professionals.</p><p><strong>Results: </strong>One hundred twenty-nine patients with 156 scans were identified from the hospital database. The data were randomly split into a training set and validation set (90%) and a test set (10%). The VGG loss function for training, validation, and test sets were 2,049.8, 2,632.6, and 4,276.9, respectively. Additionally, the structural similarity index measured 0.366, 0.356, and 0.3192, respectively. At the time of submitting the article, 23 medical professionals responded to the survey. The median overall satisfaction score was 7 of 10.</p><p><strong>Conclusion: </strong>Our network would open the door for using lightweight models in performing artificial contrast enhancement. Further research is necessary in this field to reach the point of clinical practicality.</p>\",\"PeriodicalId\":51626,\"journal\":{\"name\":\"JCO Clinical Cancer Informatics\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2024-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JCO Clinical Cancer Informatics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1200/CCI.23.00266\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JCO Clinical Cancer Informatics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1200/CCI.23.00266","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:对比度增强对于脑肿瘤的可视化、诊断和治疗非常必要。通过这项研究,我们旨在研究通用对抗神经网络在使用轻量级模型生成基于人工智能的肿瘤增强方面的潜在作用:我们对 2020 年至 2023 年期间确诊的脑肿瘤患者的磁共振成像扫描结果进行了回顾性研究。研究建立了一个生成对抗神经网络,以生成模拟这些肿瘤真实对比度增强的图像。神经网络的性能通过 VGG-16、ResNet、二元交叉熵损失、平均绝对误差、平均平方误差和结构相似性指数等指标进行定量评估。在定性评估方面,从测试集中随机选取了九个病例,并利用这些病例为有经验的医学专业人员制作了一份简短的满意度调查表:从医院数据库中找出了 129 名患者,共 156 次扫描。数据被随机分成训练集和验证集(90%)以及测试集(10%)。训练集、验证集和测试集的 VGG 损失函数分别为 2,049.8、2,632.6 和 4,276.9。此外,结构相似性指数分别为 0.366、0.356 和 0.3192。在提交文章时,共有 23 位医疗专业人士对调查做出了回应。总体满意度的中位数为 7 分(满分 10 分):我们的网络将为使用轻量级模型进行人工对比度增强打开一扇大门。要达到临床实用性,还需要在这一领域开展进一步的研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Potential Role of Generative Adversarial Networks in Enhancing Brain Tumors.

Purpose: Contrast enhancement is necessary for visualizing, diagnosing, and treating brain tumors. Through this study, we aimed to examine the potential role of general adversarial neural networks in generating artificial intelligence-based enhancement of tumors using a lightweight model.

Patients and methods: A retrospective study was conducted on magnetic resonance imaging scans of patients diagnosed with brain tumors between 2020 and 2023. A generative adversarial neural network was built to generate images that would mimic the real contrast enhancement of these tumors. The performance of the neural network was evaluated quantitatively by VGG-16, ResNet, binary cross-entropy loss, mean absolute error, mean squared error, and structural similarity index measures. Regarding the qualitative evaluation, nine cases were randomly selected from the test set and were used to build a short satisfaction survey for experienced medical professionals.

Results: One hundred twenty-nine patients with 156 scans were identified from the hospital database. The data were randomly split into a training set and validation set (90%) and a test set (10%). The VGG loss function for training, validation, and test sets were 2,049.8, 2,632.6, and 4,276.9, respectively. Additionally, the structural similarity index measured 0.366, 0.356, and 0.3192, respectively. At the time of submitting the article, 23 medical professionals responded to the survey. The median overall satisfaction score was 7 of 10.

Conclusion: Our network would open the door for using lightweight models in performing artificial contrast enhancement. Further research is necessary in this field to reach the point of clinical practicality.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
6.20
自引率
4.80%
发文量
190
期刊最新文献
Increasing Power in Phase III Oncology Trials With Multivariable Regression: An Empirical Assessment of 535 Primary End Point Analyses. Validation of Non-Small Cell Lung Cancer Clinical Insights Using a Generalized Oncology Natural Language Processing Model. Interinstitutional Approach to Advancing Geospatial Technologies for US Cancer Centers. Classification and Regression Trees to Predict for Survival for Patients With Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab. Cureit: An End-to-End Pipeline for Implementing Mixture Cure Models With an Application to Liposarcoma Data.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1